This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20170915 PLA WGM"
Jump to navigation
Jump to search
| Line 38: | Line 38: | ||
===============================================================================---> | ===============================================================================---> | ||
|- | |- | ||
| − | | || Calvin Beebe | + | |x || Calvin Beebe |
|- | |- | ||
| ||Lorraine Constable | | ||Lorraine Constable | ||
| Line 44: | Line 44: | ||
| || Jean Duteau, | | || Jean Duteau, | ||
|- | |- | ||
| − | | || Tony Julian | + | |x || Tony Julian |
|- | |- | ||
| − | | || Paul Knapp | + | |x || Paul Knapp |
|- | |- | ||
| − | | || Austin Kreisler, | + | |x || Austin Kreisler, |
|- | |- | ||
| − | | || Mary Kay McDaniel | + | |x || Mary Kay McDaniel |
|- | |- | ||
| || Brian Pech | | || Brian Pech | ||
| Line 84: | Line 84: | ||
===Minutes=== | ===Minutes=== | ||
| − | + | Agenda review | |
| − | + | *Notes of [[20170901_PLA_call]] review | |
| − | + | *Discussion Topics | |
| + | **CIMI Product Family progress/CDAMG progress | ||
| + | ***Mary Kay attended CIMI. Doesn’t think the members of CIMI are all in with the idea of a product management group. Counseled them on the benefits. Several people approached her about being on the management group. Austin notes we’ll be putting out a formal call for candidates when the mission and charter is complete. Austin gave an update at the facilitator’s roundtable about the CDAMG and how it will function. Met with 2.x publishing group; they are saying that their attendance is thin. Not much participation in further development of 2.x. Core activity is coming out of OO and InM. It is a mature standard with little change. V3 will no longer support new content requests, but will continue to support the ones we have. Talked about the topic of formalizing a CIMI product family but not much feedback from that group. | ||
| + | ***Discussion over need to go back through a risk assessment process. Should look at having a conversation with Pat as she did the last risk assessment project. Shifting structure is necessitating a fresh review. Need visibility of where all of our rules are and who is responsible for what decisions. | ||
| + | ***Need to articulate the implications of the RACI chart, and develop the rules of engagement for each of the new groups, showing who each group relates to and how. | ||
| + | **Conference call schedule | ||
| + | ***Latest call was 11:30 Eastern – decision to keep it at every other week starting in two weeks. | ||
===Meeting Outcomes=== | ===Meeting Outcomes=== | ||
Revision as of 20:36, 21 September 2017
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA WGM Minutes Location: TBD |
Date: 2017-09-15 Time: 8:00 AM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| x | Calvin Beebe | ||
| Lorraine Constable | |||
| Jean Duteau, | |||
| x | Tony Julian | ||
| x | Paul Knapp | ||
| x | Austin Kreisler, | ||
| x | Mary Kay McDaniel | ||
| Brian Pech | |||
| Wayne Kubick | |||
| John Roberts | |||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20170901_PLA_call review
- Discussion Topics
- CIMI Product Family progress
- CDAMG progress
Minutes
Agenda review
- Notes of 20170901_PLA_call review
- Discussion Topics
- CIMI Product Family progress/CDAMG progress
- Mary Kay attended CIMI. Doesn’t think the members of CIMI are all in with the idea of a product management group. Counseled them on the benefits. Several people approached her about being on the management group. Austin notes we’ll be putting out a formal call for candidates when the mission and charter is complete. Austin gave an update at the facilitator’s roundtable about the CDAMG and how it will function. Met with 2.x publishing group; they are saying that their attendance is thin. Not much participation in further development of 2.x. Core activity is coming out of OO and InM. It is a mature standard with little change. V3 will no longer support new content requests, but will continue to support the ones we have. Talked about the topic of formalizing a CIMI product family but not much feedback from that group.
- Discussion over need to go back through a risk assessment process. Should look at having a conversation with Pat as she did the last risk assessment project. Shifting structure is necessitating a fresh review. Need visibility of where all of our rules are and who is responsible for what decisions.
- Need to articulate the implications of the RACI chart, and develop the rules of engagement for each of the new groups, showing who each group relates to and how.
- Conference call schedule
- Latest call was 11:30 Eastern – decision to keep it at every other week starting in two weeks.
- CIMI Product Family progress/CDAMG progress
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved
